The P21 peptide, now usually written P021, is a small lab-made compound built from a fragment of ciliary neurotrophic factor (CNTF), a natural protein that supports nerve cells.[1][2] In mice and rats it increased the birth of new brain cells, improved memory and reduced Alzheimer’s-type changes.[3][4] It has never been tested in people, and its human safety has not been assessed.[15]
What is P21 (P021)?
P021 was designed in Khalid Iqbal’s lab at the New York State Institute for Basic Research in Developmental Disabilities on Staten Island. The team first described it in 2010 as “P21,” with the structure Ac-DGGLAG-NH2.[1] It is made of four amino acids from an active region of CNTF, with an adamantane-modified glycine added to the end. That bulky, fat-loving group is meant to help it cross the blood-brain barrier and resist enzymes that break peptides down.[2]
The design grew out of the lab’s earlier, longer CNTF fragment, an 11-amino-acid compound called Peptide 6.[2] Full-size CNTF had been tried in human trials, but it caused loss of appetite, weight loss, muscle pain and stomach problems, and it does not get into the brain well.[2] A small mimic was meant to keep the benefits without those problems.
P21 peptide vs the p21 protein: a naming mix-up
Search for “p21” and most results are about a completely different molecule. p21 (also called p21WAF1/CIP1, gene name CDKN1A) is a natural protein inside cells. It blocks cyclin-dependent kinases, the switches that move cells through division, and the tumor suppressor p53 turns it on to halt the cell cycle after stress or DNA damage.[16]
The P21 peptide has nothing to do with that protein; it simply received a similar code name in the 2010 paper.[1] Later papers from the same lab call it “P021” or “Peptide 021.”[3] When reading studies or product pages, check whether “p21” means the cell-cycle protein or the CNTF peptide.
How P021 is thought to work
According to its developers, P021 works in two linked ways:[2]
- Blocking LIF signaling: it competes with leukemia inhibitory factor, a signal that keeps neural stem cells dividing rather than maturing.
- Raising BDNF: it increases brain-derived neurotrophic factor, which supports new neurons and synapses.
In aged rats, the developers reported that P021 crossed the blood-brain barrier and lowered tau levels in the brain and spinal fluid.[5] The developers report a plasma half-life of more than 3 hours and stability in simulated stomach and intestinal fluid, which is why most studies gave it by mouth in food.[2]
What the research shows
Every P021 study so far has been in cells or animals:
| Model | Result |
|---|---|
| Healthy adult mice | Better learning and memory; more new neurons in the hippocampus[1] |
| Aged rats (22 to 24 months) | Less age-related memory decline; restored neurogenesis and higher BDNF[3] |
| Alzheimer’s model mice, treated late | Less abnormal tau and soluble amyloid-beta; memory and synapse deficits rescued[4] |
| Alzheimer’s model mice, treated early | Prevented neurodegeneration, amyloid and tau pathology and memory loss, and markedly lowered deaths[6] |
| Down syndrome model mice | Prenatal-to-weaning treatment rescued developmental delay and later memory problems[7] |
| Alzheimer’s model, prenatal treatment | Better memory at 4 months and fewer plaques at 22 months[8] |
| Aged rats and Alzheimer’s mice (retina) | Less age-related macular degeneration-like damage[9] |
| CDKL5 deficiency (Italy) | Helped nerve cells in a dish, but did not raise BDNF or fix brain structure in mice[10] |
The CDKL5 study, run mainly by a team at the University of Bologna, is the main published test outside the inventor’s own lab, and its animal results were disappointing.[10] Iqbal was a co-author.
P21 peptide dosage: what was studied
There is no studied human dose. In most mouse studies, P021 was mixed into the food at 60 nanomoles per gram of feed and given for months, in one case from 3 months of age to about 22 months.[2][6]
Nasal sprays and injections sold online have not been studied, and online doses come from sellers, not research. For other brain peptides with at least some human data, see Cerebrolysin or browse the cognitive peptides page.
P21 side effects and safety
- No human safety data: side effects in people are unknown.[15]
- Animal safety: the developers report no adverse effects after up to 18 months of oral treatment in mice, and no detectable immune reaction in rats.[2][5] Rodent studies of up to 18 months found none of the weight loss, tumors or signs of pain seen with full-length CNTF.[15]
- Unknown long-term effects: P021 is designed to boost new cell formation in the brain, and no study has looked at long-term use in people.
- Product quality: research-chemical products are not checked for identity, purity, sterility or dose.
P021 vs Dihexa and Cerebrolysin
| P021 | Dihexa | Cerebrolysin | |
|---|---|---|---|
| What it is | CNTF-derived peptide mimic[2] | Angiotensin IV-derived small molecule | Pig-brain peptide mixture |
| Proposed target | LIF signaling and BDNF[2] | HGF/c-Met | Multiple growth-factor-like effects |
| Human trials | None[15] | None (a related drug failed Alzheimer’s trials) | Many, with mixed results |
| Where it is used | Research chemical only | Research chemical only | Used in Russia, China and parts of Europe |
A 2011 mouse study, led by a University of California, San Diego team with Iqbal as a co-author, compared Cerebrolysin, which it described as containing peptides with CNTF-like activity, with Iqbal’s earlier CNTF peptides (Peptide 6 and 6A). It reported that all of them boosted new neurons, but by different routes.[12] The Journal of Alzheimer’s Disease retracted that paper in 2026.[13] The retraction covers that 2011 paper only, not the P021 studies above.
Is P21 legal?
- United States: not FDA-approved for any use. We found no registered clinical trial.[17] It is sold online only as a research chemical.
- Sports: not named on WADA’s 2026 Prohibited List. In our reading it would be banned at all times under S0, which covers substances with no current approval by any government health authority for human use. Athletes should check with their anti-doping organization.[18]
This is general information, not legal advice.
What users report
We did not find user reports on P021 from forums or review sites that meet our standards; most experience claims online come from sellers, which we do not use.
The bottom line
P021 has an unusually long run of positive mouse and rat studies for a compound sold online, including year-long Alzheimer’s prevention studies.[4][6] But nearly all come from one lab with a commercial interest, the main independent test was mixed, and no person has taken it in a published study.[10][15]
